COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care

This study will test a novel intervention to facilitate family-centered communication among Hispanic/Latino (H/L) young adult childhood cancer survivors (YA-CCS), their support persons, and their clinicians through collaboration between the clinic and a community-based organization.

Study Overview

• Status: Not yet recruiting
• Conditions: Childhood Cancer
• Intervention / Treatment: Behavioral: Family-Centered Communication Intervention

• Study Type: Interventional
• Enrollment (Estimated): 18
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Stephanie Smith, MD, MPH; Phone Number: 209-609-0208; Email: smithsm@stanford.edu

Study Locations

• United States
  • California
    • Palo Alto, California, United States, 94304
      • Stanford University
      • Contact: Stephanie Smith, MD, MPH; Phone Number: 209-609-0208; Email: smithsm@stanford.edu
      • Principal Investigator: Stephanie Smith, MD, MPH

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. Childhood cancer survivor previously treated with chemotherapy and/or radiation therapy
2. Currently age 18-25 years
3. Identifies as Hispanic/Latino
4. Currently ≥5 years post cancer diagnosis
5. Fluent in English or Spanish
6. Receives medical care at Stanford
7. Lives within Jacob's Heart service area (zip codes within Monterey, Santa Cruz, Santa Clara, San Benito Counties: https://www.jacobsheart.org/service-area)
8. Ability to understand and the willingness to provide written informed consent.

Exclusion Criteria:

1. Lack of proficiency in written and spoken English or Spanish

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Family-Centered Communication; Young Adult Cancer Survivors (YA-CCS)-support person dyads receive a family-centered communication intervention delivered by a community health worker and coordinated around a standard-of-care survivorship clinic visit.

Behavioral: Family-Centered Communication Intervention; A novel family-centered communication intervention designed to facilitate communication among Young Adult Cancer Survivors (YA-CCS), their chosen support person, and clinicians through collaboration between the clinic and a community-based organization. The intervention includes pre-visit and post-visit sessions delivered by a community health worker and timed around a standard-of-care survivorship clinic visit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Proportion of invited young adult cancer survivor-support person dyads enrolled	Feasibility assessed by the proportion of invited dyads who enroll in the study.	From recruitment initiation through completion of study enrollment, up to 24 months
Proportion of enrolled young adult cancer survivors completing all intervention components	Feasibility assessed by the proportion of enrolled young adult cancer survivor participants who complete all intervention components.	From intervention initiation through intervention completion, up to 3 weeks
Mean Theoretical Framework of Acceptability questionnaire score	Acceptability assessed using participant-reported Theoretical Framework of Acceptability (TFA) questionnaire scores. Scores range from 1-5, with higher scores indicating greater acceptability.	Post-intervention, within 2 months after intervention completion
Mean Satisfaction With Visit Preparation questionnaire score	Acceptability assessed using participant-reported Satisfaction With Visit Preparation questionnaire scores. Scores range from -10 to 10, with higher scores indicating greater satisfaction.	Post-intervention, within 2 months after intervention completion

Collaborators and Investigators

• Sponsor: Stanford University
• Collaborators: National Cancer Institute (NCI)
• Investigators: Principal Investigator: Stephanie Smith, MD, MPH, Stanford University

Study record dates

Study Major Dates

• Study Start (Estimated): July 1, 2026
• Primary Completion (Estimated): July 1, 2028
• Study Completion (Estimated): July 1, 2028

Study Registration Dates

• First Submitted: May 11, 2026
• First Submitted That Met QC Criteria: May 18, 2026
• First Posted (Actual): May 26, 2026

Study Record Updates

• Last Update Posted (Actual): May 26, 2026
• Last Update Submitted That Met QC Criteria: May 18, 2026
• Last Verified: May 1, 2026

More Information

Terms related to this study

• Keywords: cancer; young adult; hispanic
• Additional Relevant MeSH Terms: Neoplasms
• Other Study ID Numbers: IRB-85827; 5K08CA285829 (U.S. NIH Grant/Contract)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No